U.S. flag

An official website of the United States government

Here’s how you know
Here’s how you know

**Official websites use .gov**
A **.gov** website belongs to an official government organization in the United States.

**Secure .gov websites use HTTPS**
A **lock** ( A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Search Query:
			MAIN MENU

																				
              Health Topics
								All Health Topics A-Z
					
													
		

		Asthma


				

															Heart-Healthy Living


				

															High Blood Pressure


				

															Sickle Cell Disease


				

															Sleep Apnea


				

															Information & Resources on COVID-19
																				
              Health Education
								Education Programs and Initiatives
					
													
		

		The Heart Truth®


				

															Learn More Breathe Better®


				

															Blood Diseases and Disorders Education Program


				

															Publications and Resources
																				
              The Science
								Research Focus Areas
					
													
		

		Blood Disorders and Blood Safety


				

															Sleep Science and Sleep Disorders


				

															Lung Diseases


				

															Health Disparities and Inequities


				

															Heart and Vascular Diseases


				

															Precision Medicine Activities


				

															Obesity, Nutrition, and Physical Activity


				

															Population and Epidemiology Studies


				

															Women’s Health


				

															Research Topics


				

															Clinical Trials


				

															All Science A-Z
																				
              Grants and Training
								Grants and Training Home


				

															Policies and Guidelines


				

															Funding Opportunities and Contacts


				

															Training and Career Development
																				
              News and Events
								News and Events Home
					
													
		

		Email Alerts


				

															All News
					
													
		

		NHLBI News


				

															NHLBI in the Press


				

															Research Features


				

															All Events
					
													
		

		Past Events


				

															Upcoming Events
																				
              About NHLBI
								About NHLBI Home
					
													
		

		Mission and Strategic Vision


				

															Leadership


				

															Divisions, Offices and Centers


				

															Advisory Committees


				

															Budget and Legislative Information


				

															Jobs and Working at the NHLBI


				

															Contact and FAQs


				

															NIH Sleep Research Plan
						
						HOME
		Search Text: Home/< Back ToThe Science/National Emphysema Treatment Trial (NETT)

National Emphysema Treatment Trial (NETT)
                        
                                                Project began
            1996
              Project ended
            2005
              Point of contact
            Antonello Punturieri, M.D., Ph.D.
                                        On this page
                        At a Glance
                                                                                                                    Key Findings
                                                            How It's Conducted
        What was the goal of the NETT?
                        
            The NETT was the first multi-center trial to study whether lung volume reduction surgery (LVRS) was a safe and effective treatment for patients with chronic obstructive pulmonary disease (COPD) of the mainly emphysema type. A secondary objective of the NETT was to identify criteria to select patients who would benefit the most from LVRS.

LVRS was first used to treat emphysema in the 1950s. In LVRS, 20% to 35% of the most damaged regions of each lung is removed on the theory that reducing lung size would pull open the airways and allow the breathing muscles to return to a more normal and comfortable position, making breathing easier and easing symptoms. Although some patients seemed to improve after the surgery, a high risk of death or complications associated with LVRS prevented its widespread use. In the early 1990s, some physicians began using LVRS again.

In response to the community’s concerns about the safety and effectiveness of LVRS, the NHLBI in 1995 convened a workshop of experts in the treatment of emphysema. The experts proposed a systematic scientific study of LVRS. At the same time, an independent study requested and funded by the Health Care Financing Administration, now known as the Centers for Medicare and Medicaid Services (CMS), found that there were not enough data on the risks and benefits of LVRS to justify unrestricted Medicare reimbursement. The CMS also recommended a scientific study of LVRS.
                AT A GLANCE
                                        The NHLBI, in collaboration with other federal government agencies, launched the NETT in 1996.
          The 17 NETT clinical centers studied more than 1,200 patients who had severe emphysema.
          The NETT clarified the short-term and long-term risks and benefits of LVRS as a treatment for severe emphysema.
          The NETT helped to identify patients who would benefit from LVRS, which led Medicare to cover LVRS treatment for select patients based upon data from the NETT.
            What were the key findings of the NETT?
    The NETT determined the benefits, risks, and cost-effectiveness of LVRS treatment of COPD with emphysema. The NETT results reported in 2003 led to Medicare coverage of LVRS for patients meeting certain criteria, based on the study results.
    More Information
      
	-
		National Emphysema Treatment Trial (NETT)
    **Benefits**

Results of the NETT showed that, on average, patients who received LVRS with medical therapy were more likely to function better after 2 years and did not face an increased risk of death, compared with patients who received medical therapy alone. The effects of LVRS varied widely among patients, however.

Researchers identified two characteristics — emphysema mostly in the upper lobes of the lungs and low exercise capacity — that helped predict which patients would benefit from surgery. Patients with both characteristics were more likely to survive longer and function better after LVRS. Patients with only one of these characteristics received some benefit from the surgery, although surgery did not increase survival time for these patients.

**Risks**

For patients whose emphysema was not in the upper lobes and who had greater exercise capacity, LVRS reduced survival time and failed to improve functional levels. Early in the study, researchers stopped enrolling patients with severe airflow obstruction and either limited ability to exchange oxygen when breathing or widespread damage in the lungs. The researchers determined that these patients received little benefit from LVRS and were at high risk of death from the procedure.

**Cost Effectiveness**

For the LVRS group, average costs were very high in the first year following surgery. In the third year of follow-up, however, total medical care costs were equivalent in the LVRS group and the group that received medical therapy only.

NETT investigators concluded that if the benefits from LVRS were maintained, the cost effectiveness of surgery added to medical therapy could ultimately approach levels consistent with other treatments that are considered of good value. This outcome would be especially likely for patients found to gain the most from LVRS — those with upper-lobe emphysema and low exercise capacity.
              How was the National Emphysema Treatment Trial conducted?
    The NETT began in 1996 as a cooperative effort between the NHLBI and CMS to study the risks and benefits of LVRS. In addition, the Agency for Healthcare Research and Quality (AHRQ) contributed support for an analysis of the cost effectiveness of LVRS based on NETT data.
    More Information
      
	-
		National Emphysema Treatment Trial (NETT)
    At the start of the study, participants completed a 6- to 10-week pulmonary rehabilitation program, which included education, counselling, exercise training, and other techniques to help them understand and manage their condition. Patients also received medicines and oxygen as needed. Participants were then randomly assigned either to continue this treatment or to have LVRS in addition to continued medical treatment.

While participants remained under the care of their own physicians, the NETT evaluated participants at 6 months, 1 year, and every year thereafter until the NETT ended. NETT researchers measured lung function, quality-of-life scores, shortness of breath, and exercise capacity, in addition to survival, illness, and hospitalization rates.

NETT investigators monitored participants for an average of 29 months before reporting their findings in 2003. Investigators followed up with participants for 2 additional years and found that, for patients who benefited from LVRS, the benefits continued during that time. The NETT ended in 2005. NETT investigators also conducted a prospective cost-effectiveness analysis over 3 years of follow-up as part of the trial.
                                Related Scientific Focus Areas
                                    Lung Diseases
                                                                                                                                                                Related Health Topics
                                    What Is COPD?
              The Lungs Back To Top Link
  

        

        Back to top
  Web Policies & Notices
  

        

              Accessibility
                      No FEAR Act Data
                      Privacy Policy
                      Freedom of Information Act (FOIA)
                      HHS Vulnerability Disclosure
    
          Related Government Websites
  

        

              Health and Human Services
                      National Institutes of Health
                      Office of the Inspector General
                      USA.gov
    
          Stay Connected
    
      
            chat bubblesLive ChatLive Chat with us, Monday through Friday, 8:30 a.m. to 5:00 p.m. EST.envelopeGet Email AlertsReceive automatic alerts about NHLBI related news and highlights from across the Institute.
  Footer Bottom
  

        



Contact Us
                            Site Index
                            Jobs